Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

Abstract The combination of immune checkpoint inhibitors (ICIs) with chemotherapy (chemoimmunotherapy) in the neoadjuvant setting have achieved favorable clinical benefits in non-small cell lung cancer (NSCLC), but the mechanism of clinical responses remain unclear. We provide a rich resource of 186...

Full description

Bibliographic Details
Main Authors: Zhenzhen Hui, Jiali Zhang, Yulin Ren, Xiaoling Li, Cihui Yan, Wenwen Yu, Tao Wang, Shanshan Xiao, Yulong Chen, Ran Zhang, Feng Wei, Jian You, Xiubao Ren
Format: Article
Language:English
Published: Nature Publishing Group 2022-07-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05057-4

Internet

https://doi.org/10.1038/s41419-022-05057-4

Similar Items